Korean J Otolaryngol-Head Neck Surg.  2002 Jun;45(6):538-543.

Morphological Changes of Cochlear Structures after Cisplatin Administration

Affiliations
  • 1Department of Otolaryngology, College of Medicine Konkuk University, Cheongju, Korea. bhkim@kku.ac.kr
  • 2Department of Anatomy, College of Medicine Konkuk University, Cheongju, Korea.

Abstract

BACKGROUND AND OBJECTIVES: Cisplatin is frequently used in the treatment of various forms of malignancies. It's therapeutic efficacy, however, is limited due to the occurrence of sensorineural hearing loss. Little is known about the course of hearing loss after cessation of cisplatin administration. We observed the cochlear duct morphology with normal and cisplatin treated animals.
MATERIALS AND METHODS
Healthy rats (strain Sprague-Dawly, weighting 80-100 mg) were used for all experiments. Total 15 rats were selected. They were divided into two groups, a treated group and a control. Four survival groups (n=3, respectively) were assigned as the treated group. After treatment with cisplatin, each survival group was sacrificed 1, 4, 10, 20 days. Except for the normal control (n=3), twelve animals were treated with cisplatin by daily I.P. injection of 1.5 mg/kg for 8 consecutive days.
RESULTS
One day after cessation of cisplatin administration, outer hair cells (OHCs) loss and stria vascularis were degenerated especially in the basal turn. At 4, 10, 20 days, the OHCs and stria vascularis morphology of the survival group were similar to those of the survival group at one day.
CONCLUSION
Our findings suggest cisplatin ototoxicity is predominantly involved in the basal turn of cochlear duct. This finding was significantly correlated with high frequency hearing loss of cisplatin ototoxicity.

Keyword

Cisplatin; Ototoxicity

MeSH Terms

Animals
Cisplatin*
Cochlear Duct
Hair
Hearing Loss
Hearing Loss, Sensorineural
Rats
Stria Vascularis
Cisplatin
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr